Global Transdermal Drug Delivery System Market 2013-2018 & 2023 - Market is Projected to Display a CAGR of 12.18%

Dublin, Dec. 12, 2018 (GLOBE NEWSWIRE) -- The "Global Transdermal Drug Delivery System Market: Analysis By Type (Patches, Gels), By Technique (Ionophoresis, Electroporation, Sonophoresis, Others), By End-User, By Region, By Country (2018 Edition): Trends, Opportunities and Forecast (2013-2023)" report has been added to ResearchAndMarkets.com's offering.

Global Transdermal Drug Delivery Market is projected to display a high growth represented by a CAGR of 12.18% during 2018-2023.

Over the recent years, global transdermal drug delivery system market has been witnessing growth, on account of several driving factors including rising incidence of chronic diseases, increasing healthcare awareness amongst consumers, flourishing market for minimally invasive products, new device approvals along with increasing health expenditure in developing countries.

Moreover, increase in sedentary lifestyle, obesity and stress with significant population suffering from serious consequences of hypertension, hormonal imbalance, is expected to propel the demand for transdermal drug delivery system. In this research report, the market is segmented on the basis of techniques, as well as end user.

By type, the segment of patches is predicted to hold its dominant position in the market. Amongst the regions, North America accounts for the largest regional share in the global transdermal drug delivery system market in 2018. However, Asia Pacific is predicted to advance at the highest rate. Presence of vast consumer base, particularly in emerging nations such as China and India, in addition to growing per capita expenditure on healthcare is likely to drive the regional market.

The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global transdermal drug delivery system market. Additionally, the report also highlights market entry strategies for various companies across the globe.

Key Topics Covered:

1. Research Methodology

2. Executive Summary

3. Strategic Recommendation
3.1 Increase bioavailability of poor penetration drugs and increase application of transdermal drug delivery system
3.2 APAC region to witness augmented growth in the forecast period

4. Transdermal Drug Delivery System Outlook

5. Transdermal Drug Delivery System Market: Growth and Forecast
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)

6. Transdermal Drug Delivery System Market: Segmental Analysis
6.1 Transdermal Drug Delivery System Market Size, By Type: Breakdown (%)
6.2 Global Patches Type Market Size, By Value (2013-2023)
6.3 Global Gels Type Market Size, By Value (2013-2023)
6.4 Global Transdermal Drug Delivery System Market Size, By Technique : Breakdown(%)
6.5 Global Iontophoresis Technique TDDS Market Size, By Value (2013-2023)
6.6 Global Electroporation Technique TDDS Market Size, By Value (2013-2023)
6.7 Global Sonophoresis Technique TDDS Market Size, By Value (2013-2023)
6.8 Global Others Technique TDDS Market Size, By Value (2013-2023)
6.9 Global Transdermal Drug Delivery System Market Size, By End User: Breakdown (%)
6.10 Global Hospital & Clinic Transdermal Drug Delivery System Market Size, By Value (2013-2023)
6.11 Global Homecare Transdermal Drug Delivery System Market Size, By Value (2013-2023)

7. Transdermal Drug Delivery System Market: Regional Analysis

8. Transdermal Drug Delivery System Market Dynamics
8.1 Transdermal Drug Delivery System Market Drivers
8.2 Transdermal Drug Delivery System Market Restraints
8.3 Transdermal Drug Delivery System Market Trends

9. Porter Five Force Analysis

10. SWOT Analysis

11. Supply Chain Analysis

12. Policy and Regulatory Landscape

13. Company Profiling
13.1 3M Pharmaceutical
13.2 Boehringer Ingelheim
13.3 Mylan
13.4 Novartis
13.5 GlaxoSmithKline
13.6 Noven
13.7 Lohmann Therapeutics System
13.8 Johnson & Johnson
13.9 Bayer AG
13.10 Corium International

For more information about this report visit https://www.researchandmarkets.com/research/xstd53/global?w=12

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

                    CONTACT: ResearchAndMarkets.com
                             Laura Wood, Senior Press Manager
                             press@researchandmarkets.com
                             For E.S.T Office Hours Call 1-917-300-0470
                             For U.S./CAN Toll Free Call 1-800-526-8630
                             For GMT Office Hours Call +353-1-416-8900
                    Related Topics: Transdermal and Transmucosal Drug Delivery